These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis. Terc J; Hansen A; Alston L; Hirota SA Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481 [TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway. Du J; Chen Y; Shi Y; Liu T; Cao Y; Tang Y; Ge X; Nie H; Zheng C; Li YC Inflamm Bowel Dis; 2015 Nov; 21(11):2495-506. PubMed ID: 26287999 [TBL] [Abstract][Full Text] [Related]
4. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway. Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328 [TBL] [Abstract][Full Text] [Related]
5. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. Shah YM; Ma X; Morimura K; Kim I; Gonzalez FJ Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1114-22. PubMed ID: 17170021 [TBL] [Abstract][Full Text] [Related]
7. Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesis. Suzuki M; Nagaishi T; Yamazaki M; Onizawa M; Watabe T; Sakamaki Y; Ichinose S; Totsuka M; Oshima S; Okamoto R; Shimonaka M; Yagita H; Nakamura T; Watanabe M PLoS One; 2014; 9(2):e88369. PubMed ID: 24520376 [TBL] [Abstract][Full Text] [Related]
8. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146 [TBL] [Abstract][Full Text] [Related]
9. Artemisinin protects against dextran sulfate-sodium-induced inflammatory bowel disease, which is associated with activation of the pregnane X receptor. Hu D; Wang Y; Chen Z; Ma Z; You Q; Zhang X; Zhou T; Xiao Y; Liang Q; Tan H; Xiao C; Tang X; Zhang B; Gao Y Eur J Pharmacol; 2014 Sep; 738():273-84. PubMed ID: 24886881 [TBL] [Abstract][Full Text] [Related]
10. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Wang F; Schwarz BT; Graham WV; Wang Y; Su L; Clayburgh DR; Abraham C; Turner JR Gastroenterology; 2006 Oct; 131(4):1153-63. PubMed ID: 17030185 [TBL] [Abstract][Full Text] [Related]
12. Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity. Yu M; Wang Q; Ma Y; Li L; Yu K; Zhang Z; Chen G; Li X; Xiao W; Xu P; Yang H Int J Biol Sci; 2018; 14(1):69-77. PubMed ID: 29483826 [TBL] [Abstract][Full Text] [Related]
13. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats. Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870 [TBL] [Abstract][Full Text] [Related]
14. Constitutive androstane receptor and pregnane X receptor cooperatively ameliorate DSS-induced colitis. Uehara D; Tojima H; Kakizaki S; Yamazaki Y; Horiguchi N; Takizawa D; Sato K; Yamada M; Uraoka T Dig Liver Dis; 2019 Feb; 51(2):226-235. PubMed ID: 30442521 [TBL] [Abstract][Full Text] [Related]
15. Sclareol protected against intestinal barrier dysfunction ameliorating Crohn's disease-like colitis via Nrf2/NF-B/MLCK signalling. Wang L; Song X; Zhou Y; Xia Y; Yang Z; Chen X; Shi R; Geng Z; Zhang X; Wang Y; Li J; Hu J; Zuo L Int Immunopharmacol; 2024 May; 133():112140. PubMed ID: 38669952 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological activation of ERβ by arctigenin maintains the integrity of intestinal epithelial barrier in inflammatory bowel diseases. Tao Y; Yue M; Lv C; Yun X; Qiao S; Fang Y; Wei Z; Xia Y; Dai Y FASEB J; 2020 Feb; 34(2):3069-3090. PubMed ID: 31908053 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis. Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773 [TBL] [Abstract][Full Text] [Related]
18. AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation. Ye X; Sun M Int J Mol Med; 2017 May; 39(5):1206-1214. PubMed ID: 28339048 [TBL] [Abstract][Full Text] [Related]
19. Taxifolin ameliorates lipopolysaccharide-induced intestinal epithelial barrier dysfunction via attenuating NF-kappa B/MLCK pathway in a Caco-2 cell monolayer model. Gong S; Zheng J; Zhang J; Wang Y; Xie Z; Wang Y; Han J Food Res Int; 2022 Aug; 158():111502. PubMed ID: 35840209 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability. Lapointe TK; Buret AG Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G343-51. PubMed ID: 22135309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]